MATINAS BIOPHARMA HOLDINGS, INC. Other Comprehensive Income (Loss), Tax
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Other Comprehensive Income (Loss), Tax of $221.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossTax · last filed 2026-03-31
- MATINAS BIOPHARMA HOLDINGS, INC. other comprehensive income (loss), tax for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. other comprehensive income (loss), tax for the quarter ending 2024-09-30 was $51.00K, a 67.10% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. other comprehensive income (loss), tax for the quarter ending 2024-06-30 was $83.00K, a 2.47% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. other comprehensive income (loss), tax for the quarter ending 2024-03-31 was $87.00K, a 62.01% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. other comprehensive income (loss), tax for fiscal 2024 was $221.00K, a 63.35% decline from fiscal 2023.
- MATINAS BIOPHARMA HOLDINGS, INC. other comprehensive income (loss), tax for fiscal 2023 was $603.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. other comprehensive income (loss), tax for fiscal 2022 was -$679.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. other comprehensive income (loss), tax for fiscal 2021 was -$374.00K, a 263.28% decline from fiscal 2020.
| Period end | Other Comprehensive Income (Loss), Tax 3 month | Other Comprehensive Income (Loss), Tax 3 month as first filed | Other Comprehensive Income (Loss), Tax 6 month | Other Comprehensive Income (Loss), Tax 6 month as first filed | Other Comprehensive Income (Loss), Tax 9 month | Other Comprehensive Income (Loss), Tax 9 month as first filed | Other Comprehensive Income (Loss), Tax 12 month | Other Comprehensive Income (Loss), Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $51.00K derived: sum of 2 quarters · filed 2026-03-31 | $134.00K derived: sum of 3 quarters · filed 2026-03-31 | $221.00K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $51.00K 10-Q · filed 2025-11-10 | $134.00K derived: sum of 2 quarters · filed 2025-11-10 | $221.00K 10-Q · filed 2025-11-10 | $359.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $83.00K 10-Q · filed 2025-08-14 | $170.00K 10-Q · filed 2025-08-14 | $308.00K derived: sum of 3 quarters · filed 2025-08-14 | $463.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $87.00K 10-Q · filed 2025-05-15 | $225.00K derived: sum of 2 quarters · filed 2025-05-15 | $380.00K derived: sum of 3 quarters · filed 2025-05-15 | $461.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $293.00K derived: sum of 2 quarters · filed 2025-04-15 | $374.00K derived: sum of 3 quarters · filed 2025-04-15 | $603.00K 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $155.00K 10-Q · filed 2024-11-13 | $236.00K derived: sum of 2 quarters · filed 2024-11-13 | $465.00K 10-Q · filed 2024-11-13 | $576.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $81.00K 10-Q · filed 2024-08-14 | $310.00K 10-Q · filed 2024-08-14 | $421.00K derived: sum of 3 quarters · filed 2024-08-14 | $240.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $229.00K 10-Q · filed 2024-05-09 | $340.00K derived: sum of 2 quarters · filed 2024-05-09 | $159.00K derived: sum of 3 quarters · filed 2024-05-09 | $34.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$70.00K derived: sum of 2 quarters · filed 2024-03-27 | -$195.00K derived: sum of 3 quarters · filed 2024-03-27 | -$679.00K 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$181.00K 10-Q · filed 2023-11-08 | -$181.15K 10-Q · filed 2022-11-02 | -$306.00K derived: sum of 2 quarters · filed 2023-11-08 | -$790.00K 10-Q · filed 2023-11-08 | -$790.07K 10-Q · filed 2022-11-02 | -$934.23K derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | -$125.00K 10-Q · filed 2023-08-09 | -$125.24K 10-Q · filed 2022-08-11 | -$609.00K 10-Q · filed 2023-08-09 | -$608.92K 10-Q · filed 2022-08-11 | -$753.23K derived: sum of 3 quarters · filed 2023-08-09 | -$806.07K derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | -$484.00K 10-Q · filed 2023-05-10 | -$483.68K 10-Q · filed 2022-05-12 | -$628.23K derived: sum of 2 quarters · filed 2023-05-10 | -$681.07K derived: sum of 3 quarters · filed 2023-05-10 | -$766.23K derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$144.23K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$197.07K derived: sum of 2 quarters · filed 2023-03-15 | -$282.23K derived: sum of 3 quarters · filed 2023-03-15 | -$374.00K 10-K · filed 2023-03-15 | -$373.67K 10-K · filed 2022-03-08 | |||
| 2021-09-30 | -$52.84K 10-Q · filed 2022-11-02 | -$138.00K derived: sum of 2 quarters · filed 2022-11-02 | -$229.77K 10-Q · filed 2022-11-02 | -$365.14K derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | -$85.16K 10-Q · filed 2022-08-11 | -$176.93K 10-Q · filed 2022-08-11 | -$312.30K derived: sum of 3 quarters · filed 2022-08-11 | -$426.46K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$91.77K 10-Q · filed 2022-05-12 | -$227.14K derived: sum of 2 quarters · filed 2022-05-12 | -$341.30K derived: sum of 3 quarters · filed 2022-05-12 | -$385.96K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$135.37K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | -$249.53K derived: sum of 2 quarters · filed 2022-03-11 | -$294.19K derived: sum of 3 quarters · filed 2022-03-11 | $229.05K 10-K/A · filed 2022-03-11 | ||||
| 2020-09-30 | -$114.16K 10-Q · filed 2021-11-08 | -$158.82K derived: sum of 2 quarters · filed 2021-11-08 | $364.43K 10-Q · filed 2021-11-08 | |||||
| 2020-06-30 | -$44.66K 10-Q · filed 2021-08-10 | $478.58K 10-Q · filed 2021-08-10 | ||||||
| 2020-03-31 | $523.25K 10-Q · filed 2021-05-10 | |||||||
| 2019-12-31 | -$880.00 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |